← Open Payments lookup

EMILY OMERZO: Open Payments

NPI 1457902546 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$366 in 17 payments from 10 companies in 2025. Trend: 2023 $160 · 2024 $305 · 2025 $366

Food & beverage: $366
CompanyPaymentsAmount
ABBVIE INC.4$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$47
E.R. Squibb & Sons, L.L.C.2$41
Lundbeck LLC2$41
Otsuka America Pharmaceutical, Inc.2$40
Alkermes, Inc.1$26
Teva Pharmaceuticals USA, Inc.1$24
Otsuka Pharmaceutical Development & Commercialization, Inc.1$24
Janssen Pharmaceuticals, Inc1$23
Supernus Pharmaceuticals, Inc.1$19

Products named: VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII, COBENFY, REXULTI, LYBALVI, UZEDY, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.